Recent findings from preclinical AD models include fewer tyrosine hydroxylase positive (TH+) neurons commensurate with decreased dopamine (DA) release2, aberrant DA neuron firing patterns3,4, and increased DA receptor expression, particularly in the ventral tegmental area (VTA)5. The gene discussed is TH; the disease is Alzheimer disease.